Oropouche

Oropouche virus circulates in parts of South and Central America and the Caribbean, historically causing periodic urban outbreaks with symptoms that closely resemble dengue, chikungunya, and Zika, which complicates diagnosis. Cases have expanded into new areas in recent years, drawing renewed attention from regional health authorities. Because it is spread by a tiny biting midge rather than a mosquito, standard mosquito-control programs may not fully address transmission risk. Virus Tracker highlights available regional signals to support comparative situational awareness alongside other arboviral diseases.

The primary vector is a tiny biting midge (Culicoides paraensis), though some mosquito species may also play a role in transmission. Emerging evidence also suggests possible transmission from a pregnant woman to her fetus, prompting increased monitoring during pregnancy.

Illness typically includes fever, severe headache, muscle and joint pain, chills, and sometimes nausea and rash, closely resembling dengue and other arboviral infections. Most cases resolve within about a week, though some people experience recurring symptoms afterward. Rare severe outcomes, including possible links to adverse pregnancy outcomes, are under active investigation.

There is no vaccine, so prevention relies on avoiding bites from midges and mosquitoes through repellent use, protective clothing, and fine-mesh screening, since standard mosquito netting may not block the smaller midge vector. Pregnant travelers to affected areas may wish to take extra precautions given ongoing research into pregnancy risk.

Surveillance depends on clinical suspicion combined with laboratory testing, since symptoms overlap heavily with other arboviral diseases circulating in the same regions. Expanding laboratory capacity and genomic sequencing have helped confirm the geographic spread of recent outbreaks.

Related pathogens